Build **GlucoShield AI**—a $25K/year B2B SaaS + telehealth compliance platform that **automates GLP-1 prescribing safety** and **blocks fraudulent middlemen**. The platform would: (1) Deploy **‘ScriptGuard’**: An LLM-driven prescription validation engine that cross-references FDA’s 2026 draft guidance, DEA schedules, and patient EHRs (e.g., Epic, Cerner) to flag non-compliant orders (e.g., ‘Script #XYZ: Rejected—no prior diabetes diagnosis’); (2) Provide a **‘Fraud Detection Dashboard’** showing real-time suspicious activity (e.g., ‘300% spike in semaglutide orders from IP: 192.168.XX.XX—flagged as Telegram bot’); (3) Integrate with **telehealth APIs (e.g., Doxy.me, Teladoc)** and **payment processors (Stripe, PayPal)** to auto-reject high-risk transactions; (4) Offer a **‘Patient Safety Monitor’** that tracks side effects via wearables (e.g., Apple Watch, Dexcom) and auto-triggers alerts (e.g., ‘Patient #ABC: Heart rate >100 bpm—alert prescriber’); (5) Include a **‘Middleman Blocklist’** that auto-denies orders from known fraudulent actors (e.g., ‘Domain: GLP1sForCheap.com—blocked’).

Validated on That's Missing platform | Status: Active Opportunity